Wednesday, September 23, 2026

Hello, You Took a Look. Here’s 25% Off.

Greetings!


You showed interest. So we wanted to follow up.


You recently took a look at GMP in Practice: What Inspectors Expect for 2026, and with the live workshop now less than 24 hours away, we wanted to offer you something as a small thank-you.


25% OFF

ANY WORKSHOP OPTION


Use code THANKYOU25 at checkout*


Choose Live, Recorded, or Live + Recorded.


Live Workshop:

Thursday, September 24 | 2:00 PM to 4:00 PM EST


*Offer valid until 9:00 AM EST on September 24.

LIVE TOMORROW. OR LEARN ON YOUR SCHEDULE.


Live

Join the instructor in real time and bring your questions.


Recorded

Access the workshop on demand.


Live + Recorded

Attend tomorrow and keep the recorded workshop for later.

WORKSHOP SCHEDULE & ACCESS

Live:

Sep 24, 2026

2:00 PM - 4:00 PM (EST)

Recorded:

On-Demand Access

(Processed within 2-3 business days)

Workshop Options

Live & Instructor-led | Recorded | Live + Recorded

Interested in this workshop?

Register today by calling our team at 416-628-7575 or email us at events@aapspharma.com

LinkedIn  Web

Hello, 50% Off the Regulatory Affairs Course You Need

 

Greetings!


YOU DON’T NEED TO LEARN EVERYTHING.


You just need to know what you need next.


Maybe your work suddenly touches Medical Devices.


Maybe someone says CMC and you want to understand more than your piece of it.


Maybe it’s Clinical Research. Natural Health Products. Submissions. Compliance.


There’s probably one part of Regulatory Affairs you’ve been meaning to understand better.


Start with that.

 
 

THROUGH SEPTEMBER 30


REGULAR COURSE FEE

50% OFF

ONE COURSE. YOUR CHOICE.


Individual Professional Regulatory Affairs courses are available at 50% of their regular course fees through September 30.


INDIVIDUAL COURSES • REGULATORY AFFAIRS • AAPS

 
 
 

SO, WHAT DO YOU WANT TO KNOW BETTER?


Four places you could start.

💊 NATURAL HEALTH PRODUCTS


PRA205



Regulatory Affairs

Natural Health Product

⚕️ MEDICAL DEVICES


PRA204



Regulatory Affairs

Medical Device

🔬 CLINICAL + PRECLINICAL


PRA202



Regulatory Affairs for Clinical

Research and Preclinical - Drugs

🧪 CMC


PRA304



Chemistry, Manufacturing

and Control

 

MAYBE YOUR “ONE THING” ISN’T ONE OF THOSE.


GOOD. THERE’S MORE.


🟧 PRA101 | START WITH THE FOUNDATION

Introduction to Regulatory Affairs


🟧 PRA201 | GET CLOSER TO SUBMISSIONS

Pharma Regulatory Submissions, Labeling and Product Summaries


🟧 PRA203 | EXPLORE BIOTECH & BIOLOGICS

Regulatory Affairs Biotech/Biologics


🟧 PRA301 | WHAT HAPPENS AFTER APPROVAL?

Post Approval Activities and Compliance


🟧 PRA302 | UNDERSTAND GENERIC DRUGS

Regulatory Affairs Generic Drugs


🟧 PRA303 | EXPLORE IP

Intellectual Property



🟧 PRA305 | THINK GLOBAL

Global Regulatory Affairs

 
 

Maybe you already know which one.


Maybe there are two or three areas you've been meaning to understand better.


You don't have to solve your entire career in one go.



Start with what's useful to you.

 
 

THE COURSE YOU'VE BEEN MEANING TO TAKE.


50% OFF


THROUGH

SEPTEMBER 30


Professional Regulatory Affairs

Individual Courses


You probably already know what you want to understand better.



Start there.

Offer applies to individual Professional Regulatory Affairs courses through September 30.

 

Interested in AAPS College?

Register today by calling our team at 416-502-2277 or email us at info@aaps.ca.

LinkedIn  Facebook  Instagram  Web  YouTube

Tuesday, September 22, 2026

Hello, FDA Put AI in a Warning Letter. We Need to Talk.


Greetings!


AI JUST BECAME A QUALITY ISSUE.


Not theoretically. Not someday.


FDA has now cited inappropriate use of AI in pharmaceutical manufacturing.


And that leaves Quality teams with a question that’s getting harder to ignore:

How much AI-generated work is already entering your Quality Unit?


And would your existing quality systems catch it?

 

SPECIAL WEBINAR ACCESS


$99

$0

YES. THIS ONE’S ON US.


Join the live webinar at no cost with promo code:

SAVE99

October 8 | 12-1 PM EST

LIVE • INTERACTIVE • INSTRUCTOR-LED

[REGISTER FOR $0]

 

THE WARNING LETTER WAS THE WAKE-UP CALL.


The bigger story is what happens next.


AI doesn’t necessarily arrive in a Quality Unit through some huge company-wide implementation.



It can show up much more quietly.

DOCUMENTATION

AI-assisted

drafting

REVIEW

AI-generated

summaries

DECISIONS

AI-supported

analysis

“SHADOW AI”

Tools being used

outside formal systems

The technology may be new. Your responsibility for the output isn’t.

 
 

This is about what happens when AI meets Quality.


🟠WHAT FDA ACTUALLY CITED

What made this warning letter different.


🟠WHERE “SHADOW AI” APPEARS

How AI can quietly enter otherwise well-run Quality Units.


🟠HOW TO THINK ABOUT AI RISK

Because different uses of AI create different considerations.



🟠WHETHER YOUR CONTROLS ARE READY

Document control. Attribution. Training. Validation. Review.

 
 

THIS CONVERSATION IS FOR YOU IF YOU WORK IN:

QA | QC | REGULATORY AFFAIRS | CMC | VALIDATION

 
 

ONE HOUR. ONE VERY TIMELY CONVERSATION.


$99 → $0

USE CODE SAVE99


October 8, 2026

12:00 PM - 1:00 PM EST


AI in the Quality Unit:

What FDA’s First AI Warning Letter Didn’t Tell You

Enter SAVE99 at registration to reduce your registration cost to $0.

 

Interested in this workshop?

Register today by calling our team at 416-628-7575 or email us at events@aapspharma.com

LinkedIn  Web